FDA Investigating Quality Issues That Led To Millions Of J&J Vaccines To Be Thrown Out

The FDA is launching a probe of the recent quality concerns over J&J vaccines. Jonathan Javitt M.D., CEO of NeuroRX and adjunct professor at Johns Hopkins School of Medicine joins Cheddar to discuss his company's newest treatment option and the latest on various COVID-19 vaccines.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.